Intermittent Catheters Global Market Report 2024

The intermittent catheters market has grown strongly in recent years. It will grow from $2.44 billion in 2023 to $2.6 billion in 2024 at a compound annual growth rate (CAGR) of 6.6%. The expansion observed in the historical period can be attributed to factors such as the increased aging population, a higher incidence of neurological disorders, awareness and education initiatives, improvements in healthcare infrastructure, and a growing preference among patients for home healthcare.

The intermittent catheters market is expected to see strong growth in the next few years. It will grow to $3.31 billion in 2028 at a compound annual growth rate (CAGR) of 6.3%. The anticipated growth in the forecast period can be attributed to factors including the rise in chronic conditions, a heightened focus on infection prevention, healthcare cost containment strategies, the adoption of personalized healthcare solutions, and the increased utilization of telehealth and remote patient monitoring. Key trends expected in the forecast period encompass technological innovations in catheter design, advancements in medical technology, an increased emphasis on patient convenience and quality of life, considerations of economic and reimbursement factors, as well as initiatives for global expansion and market penetration.

The anticipated rise in the prevalence of urinary incontinence is expected to drive the growth of the intermittent catheter market in the coming years. Urinary incontinence (UI) is characterized by the loss of bladder control or the inability to manage urination. Individuals suffering from urinary incontinence often use intermittent catheters, self-catheterizing four to six times a day to regain bladder control. The increasing prevalence of urinary incontinence is set to fuel the demand for intermittent catheters. For example, a report by the National Association for Continence reveals that globally, 200 million people experience urinary incontinence, with 75% to 80% of the 25 million adult Americans affected being female. Stress urinary incontinence, the predominant type among women, is estimated to impact 15 million adult women in the United States. Hence, the growth of the intermittent catheter market is closely tied to the increasing prevalence of urinary incontinence.

The expected rise in healthcare expenditure is likely to contribute to the expansion of the intermittent catheters market. Healthcare expenditure encompasses spending on healthcare goods and services, representing the total amount of money invested in healthcare within a specific system or economy. The role of healthcare expenditure is pivotal in supporting the development and accessibility of intermittent catheters. For instance, data from the Canadian Institute for Health Information in November 2022 indicates that healthcare expenditure increased to 0.8%, totaling $331 billion in 2022, compared to 7.6% in 2021. Consequently, the growth of the intermittent catheters market is influenced by the upward trajectory of healthcare expenditure.

A key trend gaining momentum in the intermittent catheter market is product innovation. Major companies in this market are prioritizing the development of innovative products to maintain their competitive positions. For instance, in February 2023, Denmark-based Coloplast Corp introduced Luja, a male intermittent catheter designed to address significant risk factors for urinary tract infections (UTIs). Luja, featuring Micro-hole Zone Technology, sets a new benchmark for intermittent catheterization by ensuring full bladder emptying in a single free flow. This innovation is poised to revolutionize continence care, offering benefits to both catheter users and the broader healthcare industry.

Leading companies in the intermittent catheters market are investing in innovative technologies such as Feel Clean technology to gain a competitive edge. Feel Clean technology, applied to intermittent catheters, involves a specialized surface coating or treatment aimed at enhancing the user experience by reducing residual stickiness or residue post-use. For instance, in September 2022, UK-based Convatec launched the GentleCathTM range of catheters, incorporating the pioneering FeelClean technology to address challenges associated with intermittent catheterization. This next-generation material, intrinsically slippery when wet and without the need for a coating, exhibits low friction during insertion and avoids becoming sticky upon removal.

In March 2021, UK-based medical products and technologies company Convatec Inc. acquired Cure Medical LLC for an undisclosed amount. This strategic acquisition aligns with Convatec's objectives by sharpening its focus on the U.S., the market with the highest demand for continence care solutions. The common goal of both businesses is to enhance care for clients and patients. Cure Medical LLC, a U.S.-based manufacturer of intermittent catheters, contributes to Convatec's position in the market.

Major companies operating in the intermittent catheters market report are Adapta Medical Inc., B. Braun SE, Becton Dickinson and Company, Coloplast Corp., Cure Medical LLC, Hollister Incorporated, Hunter Urology Ltd., Teleflex Incorporation, Convatec Group plc, Medical Technologies of Georgia Inc., Cook Group Incorporate, McKesson Medical-Surgical Inc., Medline Industries LP, Romsons Group, Wellspect HealthCare AB, Asid Bonz GmbH, Bard Medical Division, Boston Scientific Corporation, Medtronic PLC, J and M Urinary Catheters LLC, Mahindra & Mahindra Limited, AGCO Corporation, Concern Tractor Plants, Escorts Group, Advin Healthcare, Rhythm Surgical.

North America was the largest region in the intermittent catheters market in 2023. The regions covered in the intermittent catheters market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the intermittent catheters market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The primary products within the category of intermittent catheters include uncoated intermittent catheters and coated intermittent catheters. Uncoated intermittent catheters encompass regular variants and are further categorized as male length catheters, kid length catheters, and female length catheters. These catheters find application in various medical contexts such as urinary incontinence, urinary retention, prostate gland surgery, spinal cord injury, and others. Their usage is prevalent in surgical centers, specialty clinics, academic and research institutions.

The intermittent catheters market research report provides intermittent catheters market statistics, including intermittent catheters industry global market size, regional shares, competitors with intermittent catheters market share, detailed intermittent catheters market segments, market trends, and opportunities, and any further data you may need to thrive in the intermittent catheters industry. This intermittent catheter market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The intermittent catheter market consists of sales of latex, vinyl, polyvinyl chloride, silicone, and polyurethane catheters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.